20
Participants
Start Date
December 1, 2025
Primary Completion Date
July 1, 2027
Study Completion Date
July 1, 2028
5-ALA
5-ALA), also known by its brand name Gleolan, is an intermediate in the heme synthesis pathway that has been studied in tumor resections, especially in intracranial tumor resections. One advantage of intraoperative visualization with 5-ALA is the ability to directly visualize fluorescent tumor in the surgical field using a headset-mounted devices with fluorescence in the visual wavelength in real-time.
University of Colorado Hospital, Aurora
Collaborators (1)
NX Development Corp
INDUSTRY
University of Colorado, Denver
OTHER